Teladoc Health, Inc.
TDOC
$7.68
$0.496.82%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -207.36M | -1.01B | -1.00B | -981.73M | -1.01B |
| Total Depreciation and Amortization | 210.96M | 228.46M | 249.81M | 270.60M | 288.81M |
| Total Amortization of Deferred Charges | 157.59M | 144.05M | 133.04M | 121.42M | 108.24M |
| Total Other Non-Cash Items | 144.09M | 965.43M | 948.40M | 963.76M | 980.49M |
| Change in Net Operating Assets | -1.85M | -24.90M | -36.32M | -36.19M | -38.73M |
| Cash from Operations | 303.43M | 300.68M | 293.68M | 337.86M | 333.29M |
| Capital Expenditure | -11.72M | -12.37M | -10.79M | -6.06M | -10.26M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -65.30M | -64.61M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -166.73M | -134.83M | -113.26M | -124.85M | -127.16M |
| Cash from Investing | -243.76M | -211.81M | -124.05M | -130.91M | -137.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -550.63M | -- | -- | -- | -- |
| Issuance of Common Stock | 4.48M | 7.61M | 8.49M | 7.54M | 10.50M |
| Repurchase of Common Stock | -176.00K | -176.00K | -176.00K | -176.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -83.00K | -106.00K | -2.00K | -2.89M | -1.65M |
| Cash from Financing | -546.41M | 7.33M | 8.31M | 4.48M | 8.85M |
| Foreign Exchange rate Adjustments | 3.97M | -804.00K | -3.29M | 1.91M | -1.03M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -482.76M | 95.40M | 174.65M | 213.34M | 203.69M |